Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212899432> ?p ?o ?g. }
- W4212899432 endingPage "398" @default.
- W4212899432 startingPage "398" @default.
- W4212899432 abstract "The world raced to develop vaccines to protect against the rapid spread of SARS-CoV-2 infection upon the recognition of COVID-19 as a global pandemic. A broad spectrum of candidates was evaluated, with mRNA-based vaccines emerging as leaders due to how quickly they were available for emergency use while providing a high level of efficacy. As a modular technology, the mRNA-based vaccines benefitted from decades of advancements in both mRNA and delivery technology prior to the current global pandemic. The fundamental lessons of the utility of mRNA as a therapeutic were pioneered by Dr. Katalin Kariko and her colleagues, perhaps most notably in collaboration with Drew Weissman at University of Pennsylvania, and this foundational work paved the way for the development of the first ever mRNA-based therapeutic authorized for human use, COMIRNATY®. In this Special Issue of Pharmaceutics, we will be honoring Dr. Kariko for her great contributions to the mRNA technology to treat diseases with unmet needs. In this review article, we will focus on the delivery platform, the lipid nanoparticle (LNP) carrier, which allowed the potential of mRNA therapeutics to be realized. Similar to the mRNA technology, the development of LNP systems has been ongoing for decades before culminating in the success of the first clinically approved siRNA-LNP product, ONPATTRO®, a treatment for an otherwise fatal genetic disease called transthyretin amyloidosis. Lessons learned from the siRNA-LNP experience enabled the translation into the mRNA platform with the eventual authorization and approval of the mRNA-LNP vaccines against COVID-19. This marks the beginning of mRNA-LNP as a pharmaceutical option to treat genetic diseases." @default.
- W4212899432 created "2022-02-24" @default.
- W4212899432 creator A5037442251 @default.
- W4212899432 creator A5038339810 @default.
- W4212899432 creator A5046154045 @default.
- W4212899432 creator A5064040222 @default.
- W4212899432 creator A5086883726 @default.
- W4212899432 date "2022-02-11" @default.
- W4212899432 modified "2023-10-05" @default.
- W4212899432 title "Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics" @default.
- W4212899432 cites W12748762 @default.
- W4212899432 cites W1420726270 @default.
- W4212899432 cites W1431508430 @default.
- W4212899432 cites W1515466910 @default.
- W4212899432 cites W1522161763 @default.
- W4212899432 cites W1528222698 @default.
- W4212899432 cites W1531431054 @default.
- W4212899432 cites W1538766821 @default.
- W4212899432 cites W1808439685 @default.
- W4212899432 cites W1902761939 @default.
- W4212899432 cites W1914506150 @default.
- W4212899432 cites W191828198 @default.
- W4212899432 cites W1966319544 @default.
- W4212899432 cites W1966334833 @default.
- W4212899432 cites W1969381321 @default.
- W4212899432 cites W1971290197 @default.
- W4212899432 cites W1977160822 @default.
- W4212899432 cites W1986178107 @default.
- W4212899432 cites W2000121122 @default.
- W4212899432 cites W2001314633 @default.
- W4212899432 cites W2009858479 @default.
- W4212899432 cites W2012774875 @default.
- W4212899432 cites W2015915232 @default.
- W4212899432 cites W2025980739 @default.
- W4212899432 cites W2029397995 @default.
- W4212899432 cites W2029984783 @default.
- W4212899432 cites W2039249037 @default.
- W4212899432 cites W2054412308 @default.
- W4212899432 cites W2058647478 @default.
- W4212899432 cites W2078775246 @default.
- W4212899432 cites W2080718344 @default.
- W4212899432 cites W2083249633 @default.
- W4212899432 cites W2084891840 @default.
- W4212899432 cites W2086747295 @default.
- W4212899432 cites W2089150369 @default.
- W4212899432 cites W2089706661 @default.
- W4212899432 cites W2095151181 @default.
- W4212899432 cites W2096039130 @default.
- W4212899432 cites W2098777190 @default.
- W4212899432 cites W2105051797 @default.
- W4212899432 cites W2106885643 @default.
- W4212899432 cites W2119464903 @default.
- W4212899432 cites W2125470506 @default.
- W4212899432 cites W2125708644 @default.
- W4212899432 cites W2128117338 @default.
- W4212899432 cites W2133732437 @default.
- W4212899432 cites W2133782648 @default.
- W4212899432 cites W2136240349 @default.
- W4212899432 cites W2143743183 @default.
- W4212899432 cites W2147584970 @default.
- W4212899432 cites W2149896139 @default.
- W4212899432 cites W2155534998 @default.
- W4212899432 cites W2156788486 @default.
- W4212899432 cites W2157979200 @default.
- W4212899432 cites W2162970812 @default.
- W4212899432 cites W2171790482 @default.
- W4212899432 cites W2173459426 @default.
- W4212899432 cites W2239786700 @default.
- W4212899432 cites W2249755146 @default.
- W4212899432 cites W2281696593 @default.
- W4212899432 cites W2323505647 @default.
- W4212899432 cites W2324654634 @default.
- W4212899432 cites W2333830073 @default.
- W4212899432 cites W2405934989 @default.
- W4212899432 cites W2417233462 @default.
- W4212899432 cites W2515313544 @default.
- W4212899432 cites W2528458398 @default.
- W4212899432 cites W2584249987 @default.
- W4212899432 cites W2587850379 @default.
- W4212899432 cites W2587871737 @default.
- W4212899432 cites W2593990758 @default.
- W4212899432 cites W2599276599 @default.
- W4212899432 cites W2609075891 @default.
- W4212899432 cites W2738515079 @default.
- W4212899432 cites W2742522266 @default.
- W4212899432 cites W2754443480 @default.
- W4212899432 cites W2767992446 @default.
- W4212899432 cites W2775712816 @default.
- W4212899432 cites W2777634859 @default.
- W4212899432 cites W2777795488 @default.
- W4212899432 cites W2782155349 @default.
- W4212899432 cites W2788997515 @default.
- W4212899432 cites W2791854174 @default.
- W4212899432 cites W2810909862 @default.
- W4212899432 cites W2825109425 @default.
- W4212899432 cites W2885263529 @default.
- W4212899432 cites W2893976143 @default.
- W4212899432 cites W2897789147 @default.